Red Cell Distribution Width (RDW) as a Prognostic Marker in ICU
NCT ID: NCT02917811
Last Updated: 2017-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2016-01-31
2016-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients
NCT07244731
Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients
NCT06847451
Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
NCT03617796
Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients
NCT07057154
Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients
NCT05431491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Hematological disease
* Age \<18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Università degli Studi di Ferrara
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Savino Spadaro
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sant'Anna Hospital
Ferrara, Ferrara, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kim CH, Park JT, Kim EJ, Han JH, Han JS, Choi JY, Han SH, Yoo TH, Kim YS, Kang SW, Oh HJ. An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Crit Care. 2013 Dec 9;17(6):R282. doi: 10.1186/cc13145.
Lorente L, Martin MM, Abreu-Gonzalez P, Sole-Violan J, Ferreres J, Labarta L, Diaz C, Gonzalez O, Garcia D, Jimenez A, Borreguero-Leon JM. Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PLoS One. 2014 Aug 25;9(8):e105436. doi: 10.1371/journal.pone.0105436. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20042016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.